, Volume 122, Issue 1, pp 27–34 | Cite as

Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats

  • N. R. Swerdlow
  • D. L. Braff
  • M. A. Geyer
  • B. K. Lipska
  • D. R. Weinberger
  • G. E. Jaskiw
Original Investigation


Sensorimotor gating of the startle reflex is impaired in humans with schizophrenia and in rats after mesolimbic D2 dopamine receptor activation. The loss of startle gating after D2 activation in rats has been used as an animal model of impaired sensorimotor gating in schizophrenia, because the ability of antipsychotics to restore startle gating in D2-activated rats correlates significantly with antipsychotic clinical potency. Substantial evidence indicates that the pathophysiology of schizophrenia includes structural and functional deficits in prefrontal and temporal regions, particularly the dorsolateral prefrontal cortex and the hippocampus and parahippocampal gyrus. The present study assessed startle gating in adult rats after ibotenic acid lesions of the medial prefrontal cortex or ventral hippocampus. Medial prefrontal cortex lesioned rats exhibited normal startle amplitude and normal sensorimotor gating, as reflected by prepulse inhibition (PPI) of the startle reflex. Hippocampus lesioned rats exhibited elevated startle amplitude, and similar to rats with medial prefrontal cortex lesions, did not show significant changes in basal PPI. Low doses of the mixed dopamine agonist apomorphine did not significantly reduce PPI in sham lesioned rats, but significantly disrupted PPI in both medial prefrontal cortex- and ventral hippo-campus lesioned rats. These data are consistent with the hypothesis that cell damage in frontal and temporal cortex increases the sensitivity to the sensorimotor gating-disruptive effects of dopamine receptor activation.

Key words

Apomorphine Dopamine Frontal cortex Hippocampus Schizophrenia Startle 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Altshuler LL, Conrad A, Kovelman JA, Scheibel A (1987) Hippocampal pyramidal cell orientation in schizophrenia Arch Gen Psychiatry 44:1094–1098Google Scholar
  2. Altshuler LL, Casanova MF, Goldberg TE, Kleinman JE (1990) The hippocampus and parahippocampus in schizophrenic, suicide, and control brains. Arch Gen Psychiatry 47:1029–1034Google Scholar
  3. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48:625–632Google Scholar
  4. Bogerts B (1985) Basal ganglia and limbic system pathology in schizophrenia. Arch Gen Psychiatry 42:784–791Google Scholar
  5. Bogerts B (1993) Recent advances in the neuropathology of schizophrenia. Schizophr Bull 19:431–445Google Scholar
  6. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia:human and animal model studies. Arch Gen Psychiatry 47:181–188Google Scholar
  7. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339–343Google Scholar
  8. Braff DL, Grillon C, Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206–215Google Scholar
  9. Braun AR, Jaskiw GE, Vladar K, Sexton R, Kolachana B, Weinberger DR (1993) Effect of ibotenic acid lesions of the medial prefrontal cortex in dopamine agonist related behaviors in the rat. Pharmacol Biochem Behav 46:51–60Google Scholar
  10. Buchsbaum MS, Ingvar DH, Kessler R (1982) Cerebral glucography with positron tomography. Arch Gen Psychiatry 39:251–259Google Scholar
  11. Buchsbaum MS, DeLisi LE, Holcomb HH (1984) Anterioposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 41:1159–1166Google Scholar
  12. Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB (1991) Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 48:413–417Google Scholar
  13. Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419–435Google Scholar
  14. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–483Google Scholar
  15. Csernansky JG, Kerr S, Pruthi R, Prosser ES (1988) Mesolimbic DA receptor increases two weeks following hippocampal kindling. Brain Res 449:357–360Google Scholar
  16. Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474–1486Google Scholar
  17. Davis M (1980) Neurochemical modulation of sensory-motor reactivity:acoustic and tactile startle reflexes. Neurosci Biobehav Rev 4:241–263Google Scholar
  18. Davis M (1984) The mammalian startle response. In: Eaton RC (ed) Neural mechanisms of startle behavior. Plenum Press, New York, pp 287–342Google Scholar
  19. Davis M, Sollberger A (1971) Twenty-four hour periodicity of the startle response in rats. Psychon Sci 25:1Google Scholar
  20. Davis M, Gendelman D, Tischler M, Gendelman P (1982) A primary acoustic startle circuit:lesion and stimulation studies. J Neurosci 2:791–805Google Scholar
  21. Early TS, Relman Em, Raichle ME, Spitzmagel EL (1987) Left globus pallidus abnormality in newly medicated patients with schizophrenia. Proc Natl Acad Sci USA 84:561–563Google Scholar
  22. Geyer M, Swerdlow NR, Mansbach RS, Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485–498Google Scholar
  23. Glick SD (1972) Changes in amphetamine sensitivity following frontal cortical damage in rats and mice. Eur J Pharmacol 20:351–356Google Scholar
  24. Graham F (1975) The more or less startling effects of weak prestimulation. Psychophysiology 12:238–248Google Scholar
  25. Hoffman DC, Donovan H (1994) D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia. Psychopharmacology 115:447–453Google Scholar
  26. Hoffman HS, Searle JL (1968) Acoustic and temporal factors in the evocation of startle. J Acoust Soc Am 43:269–282Google Scholar
  27. Ison JR, McAdam DW, Hammond GR (1973) Latency and amplitude changes in the acoustic startle reflex produced by variations in auditory prestimulation. Physiol Behav 10:1035–1039Google Scholar
  28. Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65:303–326Google Scholar
  29. Jaskiw GE, Weinberger DR (1992a) Ibotenic acid lesions of medial prefrontal cortex augment swim-stress-induced locomotion. Pharmacol Biochem Behav 41:607–609Google Scholar
  30. Jaskiw GE, Weinberger DR (1992b) Dopamine and schizophrenia — a cortically corrective perspective. Semin Neurosci 4:179–188Google Scholar
  31. Jaskiw GE, Karoum F, Freed WJ, Phillips I, Kleinman JE, Weinberger DR (1990a) Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res 534:263–272Google Scholar
  32. Jaskiw GE, Karoum F, Weinberger DR (1990b) Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex. Brain Res 534:321–323Google Scholar
  33. Jones SM, Snell LD, Johnson KM (1987) Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology 26:173–179Google Scholar
  34. Lipska BK, Jaskiw GE, Chrapusta S, Karoum F, Weinberger DR (1992) Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res 585:1–6Google Scholar
  35. Lipska BK, Jaskiw GE, Braun AR, Weinberger DR (1995a) Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Biol Psychiatry (in press)Google Scholar
  36. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995b) Neonatal excitotoxic hippocampal damage disrupts sensorimotor gating in postpubertal rats (accompanying paper)Google Scholar
  37. Luchins DJ (1990) A possible role of hippocampal dysfunction in schizophrenic symptomatology. Biol Psychiatry 28:87–91Google Scholar
  38. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507–514Google Scholar
  39. McGhie A, Chapman J (1961) Disorders of attention and perception in early schizophrenia. Br J Med Psychol 34:102–116Google Scholar
  40. Pakkenberg B (1990) Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 47:1023–1028Google Scholar
  41. Peng RY, Mansbach RS, Braff DL, Geyer MA (1990) A D2dopamine receptor agonist disrupts sensorimotor gating in rats:implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology 3:211–218Google Scholar
  42. Pulvirenti L, Swerdlow NR, Koob GF (1991) Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol Biochem Behav 40:841–845Google Scholar
  43. Pycock CJ, Kerwin RW, Carter CJ (1980) Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286:74–77Google Scholar
  44. Rigdon GC, Viik K (1991) Prepulse inhibition as a screening test for potential antipsychotics. Drug Dev Res 23:91–99Google Scholar
  45. Roberts PJ, Anderson SD (1979) Stimulatory effects ofl-glutamate and related amino acids on [3H]dopamine release from the rat striatum in an in vitro model for glutamate action. J Neurochem 32:1539–1545Google Scholar
  46. Schwarzkopf SB, Mitra T, Bruno JP (1992) Sensory gating in rats depleted of dopamine as neonates:potential relevance to findings in schizophrenic patients. Biol Psychiatry 31:759–773Google Scholar
  47. Seeman P, Lee T, Chau-wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717–719Google Scholar
  48. Seeman P, Ulpian C, Bergeron C, Riederer P, Jellinger K, Babriel E, Reynolds G, Tourtellotte W (1984) Bimodal distribution of dopamine receptor densities in brain of schizophrenics. Science 225:728–731Google Scholar
  49. Sesack SR, Pickel VM (1989) Ultrastructural basis for modulatory interactions between hippocampal and dopaminergic afferents to the rat nucleus accumbens. Soc Neurosci Abstr 1229Google Scholar
  50. Siegel C, Waldo M, Mizner G, Adler LE, Freedman R (1984) Deficits in sensory gating in schizophrenic patients and their relatives:evidence obtained with auditory evoked responses. Arch Gen Psychiatry 41:607–612Google Scholar
  51. Suddath RL, Christison MD, Torrey EF, Cassanova M, Weinberger DR (1990) Anatomic abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 322:789–794Google Scholar
  52. Swerdlow NR, Geyer MA (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44:741–744Google Scholar
  53. Swerdlow NR, Geyer M, Braff D, Koob GF (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle in schizophrenics. Biol Psychiatry 21:23–33Google Scholar
  54. Swerdlow NR, Braff DL, Geyer MA (1990a) GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Res 532:146–150Google Scholar
  55. Swerdlow NR, Braff DL, Masten VL, Geyer MA (1990b) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101:414–420Google Scholar
  56. Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL (1990c) Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 100:413–416Google Scholar
  57. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) The effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine-inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530–536Google Scholar
  58. Swerdlow NR, Caine BC, Geyer MA (1992a) Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology 108:189–195Google Scholar
  59. Swerdlow NR, Caine SB, Braff DL, Geyer MA (1992b) Neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J Psychopharmacol 6:176–190Google Scholar
  60. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139–154Google Scholar
  61. Thierry A, Tassin J-P, Blanc G, Glowinski J (1979) Selective activation of the mesocortical dopamine system by stress. Nature 263:242–244Google Scholar
  62. Totterdell S, Smith AD (1989) Convergence of hippocampal and dopaminergic input into identified neurons in the nucleus accumbens of rats. J Chem Neuroanat 2:285–298Google Scholar
  63. Wan FJ, Swerdlow NR (1994) Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology 113:103–109Google Scholar
  64. Wan FJ, Geyer MA, Swerdlow NR (1995) Presynaptic dopamineglutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology (in press)Google Scholar
  65. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669Google Scholar
  66. Weinberger DR, Berman KF, Zec RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia:I regional cerebral blood flow evidence. Arch Gen Psychiatry 44:660–669Google Scholar
  67. Weinberger DR, Berman KF, Suddath R, Torrey EF (1992) Evidence for dysfunction of a prefrontal-limbic network in schizophrenia: an MRI and rCBF study of discordant monozygotic twins. Am J Psychiatry 149:890–897Google Scholar
  68. Wong D, Wagner H, Tune L, Dannals R, Pearlson G, Links J, Tamminga C, Broussolle E, Ravert H, Wilson A, Toung J, Malat J, Williams J, O'Tuama L, Snyder S, Kuhar M, Gjedde A (1986) Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234:1558–1563Google Scholar
  69. Yang CR, Mogenson GJ (1984) Electrophysiological responses of neurones in the nucleus accumbens to hippocampal stimulation and the attenuation of excitatory responses by the mesolimbic dopaminergic system. Brain Res 324:69–84Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • N. R. Swerdlow
    • 1
  • D. L. Braff
    • 1
  • M. A. Geyer
    • 1
  • B. K. Lipska
    • 2
  • D. R. Weinberger
    • 2
  • G. E. Jaskiw
    • 3
  1. 1.Department of PsychiatryUCSD School of MedicineLa JollaUSA
  2. 2.Clinical Brain Disorders BranchNIMH Neuroscience Center at St ElizabethsWashington, DCUSA
  3. 3.Psychiatry Service 116A(B)Brecksville VAMCBrecksvilleUSA

Personalised recommendations